Elizabeth Lihua Budde, M.D., Ph.D.

  • Assistant Professor, Department of Hematology & Hematopoietic Cell Transplantation
  • Hematologic Oncologist

Elizabeth Lihua Budde, M.D., Ph.D.

Research Focus :
  • Immunotherapies for Leukemia and Lymphoma
Clinical Specialties
  • Hematology/Oncology
Other Languages Spoken
  • English
  • Mandarin
Elizabeth Budde, M.D., Ph.D., is an assistant professor in the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope. Dr. Budde's academic and clinical interests include investigating and designing novel means of immunotherapy for patients with lymphoma and leukemia, and she is part of the research team investigating the use of CAR T cells to treat blood cancers and other diseases.
Board certified in medical oncology and internal medicine, Dr. Budde has received many honors and awards for her work. She was chosen as a Special Fellow in Clinical Research awardee by the Leukemia and Lymphoma Society, a recipient of the Edson Immunotherapy Pilot Award from the J. Orin Edson Foundation, and an awardee of the Stop Cancer Foundation seed grant in 2016. She is also a current recipient of the prestigious Damon Runyon Cancer Research Foundation Clinical Investigator Award (2014-2017). She has served as the principal investigator on several innovative translational research protocols and has published her work in many peer-reviewed journals and given presentations at national and international meetings.
  • 2013-present, staff physician and assistant professor, Department of Hematologic Oncology and Hematopoietic Cell Transplantation
  • 2009-2013, Acting Instructor, Department of Medicine, University of Washington, Seattle, Washington
  • 2009-2013, Attending Physician, Hematopoietic Cell Transplant Service, Seattle Cancer Care Alliance, Seattle, Washington
  • 2009-2013, Attending Physician, Lymphoma Clinic, Seattle Cancer Care Alliance, Seattle, Washington


  • 2001, Duke University of Medicine, Durham, NC, M.D., Ph.D.
  • 1995, Tongji Medical University Wuhan, Hubei, China, Bachelor of Medicine


  • 2006 - 2009, University of Washington/ Fred Hutchinson Cancer Research Center, Seattle, WA


  • 2004 - 2006, Washington University School of Medicine, St. Louis, MO


  • 2003 - 2004, Intern, Internal medicine, Washington University School of Medicine, St. Louis, MO
  • Mantle Cell Lymphoma Consortium, Lymphoma Research Foundation
  • American Society of Hematology, Member
  • American Society of Clinical Oncology
  • Chinese American Faculty Association in Southern California (President, 2016)
  • 1995, Graduation with Highest Honors, Tongji Medical University
  • 1995-1997, Graduate School Fellowship, Duke University
  • 1997-2000, Research Assistantship, Duke University
  • 1999, Graduate Student Travel Award, B Cell Biology, Keystone International Meeting
  • 2005, Best Poster Presentation in Research Category for Medical Residents, American College of Physicians, Missouri Chapter Annual Meeting
  • 2007, Participant, AACR Workshop on Molecular Biology in Clinical Oncology Workshop
  • 2008, Participant, The 13th Annual NCCN Fellow Recognition Program
  • 2009, Participant, AACR/ASCO Workshop in Clinical Cancer Research
  • 2009-2012, Special Fellow in Clinical Research, Leukemia & Lymphoma Society
  • 2010-2012, Edson Immunotherapy Pilot Award
  • 2013, Tower Cancer Foundation Research Grant
  • 2013-2015, Margaret E. Early Medical Trust Fund
  • 2013-2016, Awardee, Career Enhancement Program, City of Hope Lymphoma SPORE
  • 2013-2016, Awardee, Developmental Research Program, City of Hope Lymphoma SPORE (P50 CA 107399)
  • 2014-2016, Tim Nesvig Lymphoma Research Foundation Fellow
  • 2014-2017, Clinical investigator, Damon Runyon Cancer Research Foundation
  • 2016, Greg Wiviott and Sharon & Robert Wiviott Seed grant, Stop Cancer Foundation
Back To Top